OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study
Haixia Liu, Rui Yu, Yanan Gao, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 9, pp. 1774-1782
Open Access | Times Cited: 14
Haixia Liu, Rui Yu, Yanan Gao, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 9, pp. 1774-1782
Open Access | Times Cited: 14
Showing 14 citing articles:
Ultrathin Niobium Carbide MXenzyme for Remedying Hypertension by Antioxidative and Neuroprotective Actions
Hui Yang, Lili Xia, Xuanxuan Ye, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 26
Closed Access | Times Cited: 21
Hui Yang, Lili Xia, Xuanxuan Ye, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 26
Closed Access | Times Cited: 21
Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment
Giuseppe De Simone, Benedetta Mazza, Licia Vellucci, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 975-975
Open Access | Times Cited: 16
Giuseppe De Simone, Benedetta Mazza, Licia Vellucci, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 975-975
Open Access | Times Cited: 16
Predicting antipsychotic-induced weight gain in first episode psychosis – A field-wide systematic review and meta-analysis of non-genetic prognostic factors
Ita Fitzgerald, Laura J. Sahm, Amy Byrne, et al.
European Psychiatry (2023) Vol. 66, Iss. 1
Open Access | Times Cited: 12
Ita Fitzgerald, Laura J. Sahm, Amy Byrne, et al.
European Psychiatry (2023) Vol. 66, Iss. 1
Open Access | Times Cited: 12
Ultrathin Niobium Carbide MXenzyme for Remedying Hypertension by Antioxidative and Neuroprotective Actions
Hui Yang, Lili Xia, Xuanxuan Ye, et al.
Angewandte Chemie (2023) Vol. 135, Iss. 26
Closed Access | Times Cited: 9
Hui Yang, Lili Xia, Xuanxuan Ye, et al.
Angewandte Chemie (2023) Vol. 135, Iss. 26
Closed Access | Times Cited: 9
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study
Haixia Liu, Hua Liu, Shuling Jiang, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 9, pp. 1793-1803
Open Access | Times Cited: 13
Haixia Liu, Hua Liu, Shuling Jiang, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 9, pp. 1793-1803
Open Access | Times Cited: 13
Establishment of an assistive diagnostic model for schizophrenia with oxidative stress biomarkers
Shuying Wang, Xiuxia Yuan, Lijuan Pang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Shuying Wang, Xiuxia Yuan, Lijuan Pang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Differing Prevalence and Correlates of Metabolic Syndromes Between Chlorpromazine and Clozapine: A 10-year Retrospective Study of a Male Chinese Cohort
Donghong Cui, Zezhi Li, Mengjuan Xing, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 10, pp. 1969-1977
Open Access | Times Cited: 8
Donghong Cui, Zezhi Li, Mengjuan Xing, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 10, pp. 1969-1977
Open Access | Times Cited: 8
Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone
Zhiyong Gao, Meihong Xiu, Jiahong Liu, et al.
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Zhiyong Gao, Meihong Xiu, Jiahong Liu, et al.
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Total antioxidant capacity, obesity and clinical correlates in first-episode and drug-naïve patients with schizophrenia
Xiaoni Guan, Yuping Chen, Xin Wang, et al.
Schizophrenia Research (2023) Vol. 264, pp. 81-86
Closed Access | Times Cited: 4
Xiaoni Guan, Yuping Chen, Xin Wang, et al.
Schizophrenia Research (2023) Vol. 264, pp. 81-86
Closed Access | Times Cited: 4
Glucose Metabolism and Sex Hormones in Male Patients with Medication-naïve First-episode Schizophrenia: A Large-scale Cross-sectional Study
Meihong Xiu, Meng Hao, Cai Liu, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 13, pp. 2263-2270
Open Access
Meihong Xiu, Meng Hao, Cai Liu, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 13, pp. 2263-2270
Open Access
Variations to plasma H2O2 levels and TAC in chronical medicated and treatment-resistant male schizophrenia patients: Correlations with psychopathology
Haidong Yang, Wenxi Sun, Man Yang, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access
Haidong Yang, Wenxi Sun, Man Yang, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access
Smoking Affects the Predictive Roles of Antioxidant Enzymes in the Clinical Response to Risperidone in Schizophrenia: A Large-scale Cohort Study
Meihong Xiu, Xiuli Song, Hanlun Yang, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 10, pp. 2151-2158
Open Access | Times Cited: 1
Meihong Xiu, Xiuli Song, Hanlun Yang, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 10, pp. 2151-2158
Open Access | Times Cited: 1
Smoke, GPx activity and symptoms improvement in patients with drug-naive first-episode schizophrenia: A large-scale 12-week follow-up study
Nan Chen, Haixia Liu, Jing Yao, et al.
Asian Journal of Psychiatry (2022) Vol. 77, pp. 103267-103267
Closed Access | Times Cited: 2
Nan Chen, Haixia Liu, Jing Yao, et al.
Asian Journal of Psychiatry (2022) Vol. 77, pp. 103267-103267
Closed Access | Times Cited: 2
Smoking, Symptoms Improvement, and Total Antioxidant Capacity in Patients with Drug-naive First-episode Schizophrenia: A Prospective Cohort Study
Zhiyong Gao, Meihong Xiu, Jiahong Liu, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 10, pp. 1733-1741
Open Access
Zhiyong Gao, Meihong Xiu, Jiahong Liu, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 10, pp. 1733-1741
Open Access
